Autologous Cellular Immunotherapy in Patients With Metastatic Bladder Urothelial Carcinoma

NCT03389438 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Shortage of funds.

Conditions

Urinary Bladder Neoplasm

Interventions

BIOLOGICAL: autologous Tcm cells immunotherapy

Sponsor

Beijing Huanxing Cancer Hospital

Collaborators

[object Object]